2021
DOI: 10.25207/1608-6228-2021-28-1-16-31
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and the heart: direct and indirect impact

Abstract: Введение. По мере развития пандемии тяжелого острого респираторного синдрома COVID-19 становилась очевидной возможность тяжелых поражений новым коронавирусом SARS-CoV-2 сердечно-сосудистой системы, которые привлекают внимание исследователей и практикующих врачей во всем мире. Цель-собрать и систематизировать накопленную за последнее время информацию о патофизиологических механизмах воздействия SARS-CoV-2 на сердечно-сосудистую систему, основных острых сердечно-сосудистых осложнениях COVID-19, оценить возможнос… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 56 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…Therefore, when hospitalizing patients with suspected or confirmed COVID-19, experts recommend to determine blood levels of D-dimer, fibrinogen and other parameters of the blood coagulation system, to count the number of platelets in the blood, and, only in accordance with the test results, to prescribe antithrombotic therapy [ 21 ]. It is well known that the D-dimer blood level exceeding the upper limit of normal values more than 2 times indicates an increased risk of deep vein thrombosis of the lower extremities and thromboembolism of the pulmonary arteries [ 10 , 21 ]. In COVID-19 patients, it was proposed to consider the D-dimer blood level high if it is 3–4 times higher than the upper limit of the reference range, and extremely high if this limit is exceeded by 5–6 times or more [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, when hospitalizing patients with suspected or confirmed COVID-19, experts recommend to determine blood levels of D-dimer, fibrinogen and other parameters of the blood coagulation system, to count the number of platelets in the blood, and, only in accordance with the test results, to prescribe antithrombotic therapy [ 21 ]. It is well known that the D-dimer blood level exceeding the upper limit of normal values more than 2 times indicates an increased risk of deep vein thrombosis of the lower extremities and thromboembolism of the pulmonary arteries [ 10 , 21 ]. In COVID-19 patients, it was proposed to consider the D-dimer blood level high if it is 3–4 times higher than the upper limit of the reference range, and extremely high if this limit is exceeded by 5–6 times or more [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…with poor outcome, there were noted an increase in the D-dimer level, a decrease in the prothrombin time (PT) and activated partial thromboplastin time (APTT) [ 8 , 9 ]. Since these changes in hemostasis correspond to disseminated intravascular blood coagulation, COVID-19 is believed to be associated with venous or arterial thrombosis [ 10 ].…”
Section: Introductionmentioning
confidence: 99%